Larry Michael Mertz, Chief Technology Officer at Accelerate Diagnostics, Inc (AXDX), bought 50,000 shares at $1.60 ($80K) on 2022-08-30, disclosed to the SEC on 2022-08-30.
Open-market purchase of $80k AXDX by Chief Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AXDX | SELL | 2024-04-10 | $12K | — | Filing → |
| AXDX | SELL | 2024-04-05 | $861 | — | Filing → |
| AXDX | SELL | 2023-05-24 | $3K | — | Filing → |